Journal article
Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge
Abstract
Chlamydia trachomatis infections in women are often asymptomatic and if left untreated can lead to significant late sequelae including pelvic inflammatory disease and tubal factor infertility. Vaccine development efforts over the past three decades have been unproductive and there is no vaccine approved for use in humans. The existence of serologically distinct strains or serovars of C. trachomatis mandates a vaccine that will provide …
Authors
Bulir DC; Liang S; Lee A; Chong S; Simms E; Stone C; Kaushic C; Ashkar A; Mahony JB
Journal
Vaccine, Vol. 34, No. 34, pp. 3979–3985
Publisher
Elsevier
Publication Date
July 2016
DOI
10.1016/j.vaccine.2016.06.046
ISSN
0264-410X
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Administration, IntranasalAmino Acid SequenceAnimalsAntibodies, BacterialAntibodies, NeutralizingAntigens, BacterialBacterial SheddingBacterial VaccinesChlamydia InfectionsChlamydia muridarumFallopian TubesFemaleMiceMice, Inbred C57BLNeutralization TestsType III Secretion SystemsVaginaVirulence Factors